Effects of Rifaximin on Transit, Permeability, Fecal Microbiome and Organic Acid Excretion in Irritable Bowel Syndrome

Scintigraphy Demonstrates High Rate of False-positive Results From Glucose Breath Tests for Small Bowel Bacterial Overgrowth

(2016) Emery C. Lin et al.   Clinical Gastroenterology and Hepatology

Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders

(2015) M. Camilleri   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea

(2015) M. Pimentel   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome

(2015) M. Camilleri et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mo1268 Characterization of Stool Microbiota in Subjects With IBS-D Receiving Repeat Treatments With Rifaximin in the TARGET 3 Study

(2015) Mark Pimentel et al.   GASTROENTEROLOGY

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials

(2014) P. Schoenfeld et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effect of Increased Bile Acid Synthesis or Fecal Excretion in Irritable Bowel Syndrome-Diarrhea

(2014) Michael Camilleri et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Antibiotic Treatment of Constipation-Predominant Irritable Bowel Syndrome

(2014) Mark Pimentel et al.   DIGESTIVE DISEASES AND SCIENCES

In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth

(2014) Aikaterini Pistiki et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Coupling Genetic and Chemical Microbiome Profiling Reveals Heterogeneity of Archaeome and Bacteriome in Subsurface Biofilms That Are Dominated by the Same Archaeal Species

(2014) Alexander J. Probst et al.   PLoS One

Irritable bowel syndrome and small intestinal bacterial overgrowth: Meaningful association or unnecessary hype

(2014) Uday C Ghoshal   WORLD JOURNAL OF GASTROENTEROLOGY

Bowel Functions, Fecal Unconjugated Primary and Secondary Bile Acids, and Colonic Transit in Patients With Irritable Bowel Syndrome

(2013) Andrea Shin et al.   Clinical Gastroenterology and Hepatology

The Effect of Rifaximin on Gut Flora and Staphylococcus Resistance

(2013) Mi-Sung Kim et al.   DIGESTIVE DISEASES AND SCIENCES

Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea

(2012) Banny S. Wong et al.   Clinical Gastroenterology and Hepatology

Butyrate

(2012) Alda J. Leonel et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

The effect of aspirin and smoking on urinary excretion profiles of lactulose and mannitol in young women: toward a dynamic, aspirin augmented, test of gut mucosal permeability

(2012) I. R. Sequeira et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Metabolomics of Fecal Extracts Detects Altered Metabolic Activity of Gut Microbiota in Ulcerative Colitis and Irritable Bowel Syndrome

(2011) Gwénaëlle Le Gall et al.   JOURNAL OF PROTEOME RESEARCH

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS

(2010) D. Yu et al.   GUT

Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation

(2010) M. Camilleri et al.   NEUROGASTROENTEROLOGY AND MOTILITY

PhyloChip microarray analysis reveals altered gastrointestinal microbial communities in a rat model of colonic hypersensitivity

(2010) T. A. Nelson et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Deep-Sea Oil Plume Enriches Indigenous Oil-Degrading Bacteria

(2010) Terry C. Hazen et al.   SCIENCE

Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome

(2010) Erja Malinen   WORLD JOURNAL OF GASTROENTEROLOGY

Clinical relevance of measuring colonic permeability

(2009) V. Haas et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions

(2009) a. deiteren et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort

(2009) n. manabe et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Diarrhoea-predominant irritable bowel syndromedistinguishable by 16S rRNA gene phylotype quantifcation

(2009) Anna Lyra et al.   WORLD JOURNAL OF GASTROENTEROLOGY

A liquid chromatography/mass spectrometry method for the evaluation of intestinal permeability

(2008) Alfonso M. Lostia et al.   CLINICAL BIOCHEMISTRY

Prospective Study of Motor, Sensory, Psychologic, and Autonomic Functions in Patients With Irritable Bowel Syndrome

(2008) M CAMILLERI et al.   Clinical Gastroenterology and Hepatology